DuPont de Nemours, Inc. (DD)
| Market Cap | 17.15B -46.2% |
| Revenue (ttm) | 6.99B +49.3% |
| Net Income | 55.00M |
| EPS | 0.39 |
| Shares Out | 135.04M |
| PE Ratio | 57.64 |
| Forward PE | 16.76 |
| Dividend | $2.40 (1.89%) |
| Ex-Dividend Date | Aug 31, 2026 |
| Volume | 105,273 |
| Open | 129.19 |
| Previous Close | 127.32 |
| Day's Range | 126.79 - 129.50 |
| 52-Week Range | 100.01 - 250.20 |
| Beta | 1.09 |
| Analysts | Buy |
| Price Target | 170.00 (+34.03%) |
| Earnings Date | Aug 4, 2026 |
About DD
DuPont de Nemours, Inc. provides technology-based materials and solutions in the United States, Canada, the Asia Pacific, Latin America, Europe, the Middle East, and Africa. It operates through two segments, Healthcare & Water Technologies and Diversified Industrials. The company offers specialty components for medical devices, packaging and garments, and protective suits under the brand TYVEK; provides water filtration and separation solutions, including elements, modules, and systems serving primarily industrial wastewater and energy markets,... [Read more]
Financial Performance
Financial StatementsAnalyst Summary
According to 17 analysts, the average rating for DD stock is "Buy." The 12-month stock price target is $170.0, which is an increase of 34.03% from the latest price.
News
Baron & Budd Secures $380 Million Settlement With DuPont, Chemours, and Corteva Over North Carolina PFAS Contamination
DALLAS--(BUSINESS WIRE)--Baron & Budd has secured a $380 million settlement with DuPont, The Chemours Company, and Corteva on behalf of 11 North Carolina public entities to resolve claims arising from...
Chemours, DuPont, Corteva settle North Carolina 'forever chemicals' claims for $455 million
Chemours , DuPont and Corteva on Thursday reached a $455 million settlement with North Carolina and 11 local entities over PFAS contamination claims tied to Chemours' Fayetteville Works plant and ot...
DuPont Chemours and Corteva resolve PFAS-related claims in NC
DuPont (DD) announced that, together with Chemours (CC) and Corteva (CTVA) and its subsidiary EIDP, it has entered into a settlement with the State of North Carolina and 11 local…
Chemours, DuPont and Corteva resolve PFAS claims with $455M settlement
Chemours (CC) announced that, along with DuPont (DD) and Corteva (CTVA), it has entered into a settlement with the State of North Carolina and 11 local entities in the vicinity…
DuPont, Chemours and Corteva Reach Agreement to Resolve PFAS-Related Claims in North Carolina
Resolves litigations brought by the State of North Carolina and 11 local entities relating to PFAS and other historical discharges from Fayetteville Works, as well as the State's claims of PFAS contam...
Flow Cleanrooms & Supply Expands Availability of DuPont™ Tyvek® IsoClean® and Dupont™ Tyvek® 400 Garments
Flow Cleanrooms & Supply expands availability of DuPont™ Tyvek® cleanroom garments for contamination control in critical manufacturing environments.
DuPont Direct Lithium Extraction Team Named 2026 Sustainability Squad by Business Intelligence Group
Recognition highlights the collaborative efforts behind DuPont's recently launched end-to-end direct lithium extraction portfolio, helping accelerate the development of lithium resources needed for el...
Australia's Largest Inland Wastewater Treatment Facility Selects MemCor™ MBR System for Expansion
The Lower Molonglo Water Quality Control Center will become the largest MBR plant in Australia with the addition of a new DuPont™ MemCor™ MBR system WILMINGTON, Del., Aug. 11, 2026 /PRNewswire/ -- DuP...
DuPont price target raised to $172 from $171 at JPMorgan
JPMorgan raised the firm’s price target on DuPont (DD) to $172 from $171 and keeps an Overweight rating on the shares.
New Jersey's $2.5 billion 'forever chemicals' settlements with DuPont, 3M, others win court approval
A federal judge on Friday approved more than $2.5 billion of settlements that New Jersey reached with DuPont , Chemours , Corteva and 3M to resolve claims over pollution attributed to PFAS, also know...
DuPont price target lowered to $176 from $180 at RBC Capital
RBC Capital analyst Arun Viswanathan lowered the firm’s price target on DuPont (DD) to $176 from $180 and keeps an Outperform rating on the shares.
DuPont Wins R&D 100 Award for Innovation in Healthcare
Award-winning DuPont™ Liveo™ Pharma TPE Ultra-Low Temp Tubing advances biopharma processing applications WILMINGTON, Del., Aug. 6, 2026 /PRNewswire/ -- DuPont (NYSE: DD) today announced that it has wo...
DuPont Strengthens Corian® Design Distribution Network with Hallmark and Parksite
New distribution alignment improves regional service, increases product availability, and provides continued support for the 2026 Nature in Motion color launch WILMINGTON, Del., Aug. 5, 2026 /PRNewswi...
DuPont price target raised to $178 from $175 at UBS
UBS raised the firm’s price target on DuPont (DD) to $178 from $175 and keeps a Buy rating on the shares.
DuPont™ FilmTec™ Fortilife™ XC220 Element Named a Sustainability Product of the Year for Advancing Industrial Water Circularity
Recognition highlights breakthrough membrane technology providing ultra-high brine concentration, water reuse, and resource recovery while reducing energy-intensive treatment requirements. WILMINGTON,...
DuPont price target raised to $159 from $153 at BofA
BofA analyst Matthew DeYoe raised the firm’s price target on DuPont (DD) to $159 from $153 and keeps a Neutral rating on the shares. Q2 was “encouraging,” particularly as diversified…
DuPont de Nemours Earnings Call Transcript: Q2 2026
Second quarter results exceeded guidance with 4% organic sales growth, margin expansion, and strong free cash flow. Full-year guidance was raised, supported by robust performance in healthcare, industrial, and semiconductor markets, and a $250 million share repurchase was announced.
DuPont de Nemours Earnings release: Q2 2026
DuPont de Nemours released its Q2 2026 earnings on August 4, 2026, summarizing the period's financial results.
DuPont de Nemours Slides: Q2 2026
DuPont de Nemours has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on August 4, 2026.
DuPont de Nemours Quarterly report: Q2 2026
DuPont de Nemours has published its Q2 2026 quarterly earnings report on August 4, 2026.
DuPont reports Q2 adjusted EPS $1.88, consensus $1.76
Reports Q2 revenue $1.8B, consensus $1.81B. “We delivered another strong quarter, exceeding our financial guidance and demonstrating our focus on consistent execution” said Lori Koch, DuPont (DD) Chie...
DuPont Reports Higher Profit as Sales Rise
DuPont de Nemours reported a higher profit in the second quarter as sales rose across the chemicals and materials company's segments.
DuPont Reports Second Quarter 2026 Results
Exceeds Second Quarter 2026 Guidance Raises Full Year 2026 Guidance Second Quarter 2026 Highlights Net Sales of $1.8 billion increased 4%; organic sales increased 4% versus year-ago period GAAP Income...
DuPont launches end-to-end Direct Lithium Extraction portfolio
DuPont (DD) announced it has launched an end-to-end Direct Lithium Extraction, or DLE, portfolio comprising more than 20 products across multiple technologies, designed to improve lithium recovery and...
DuPont Launches End-to-End Portfolio to Advance Direct Lithium Extraction
Tailored direct lithium extraction solutions combine advanced sorbents, membranes, ion exchange resins, and technical expertise to enable high-performance lithium recovery across diverse brine composi...